Targeted BRAF Inhibition Impacts Survival in Melanoma Patients with High Levels of Wnt/β-Catenin Signaling
Andy J. Chien(University of Washington), Georgina V. Long(Westmead Hospital)
Cited by 51
Related Papers
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
|Nature Communications|2014|385
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma
|Nature Medicine|2025|55